Synonyms Peripheral T-cell lymphoma unspecified recurrent, 再発組織型不明の末梢性T細胞性リンパ腫, サイハツソシキガタフメイノマッショウセイTサイボウセイリンパシュ |
Introduction- |
Target |
Mechanism Top II inhibitors |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date01 Jun 2021 |
Target |
Mechanism Bcl-2 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date11 Apr 2016 |
Target |
Mechanism PD-1 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date04 Jul 2014 |
Start Date01 Sep 2021 |
Sponsor / Collaborator |
Start Date21 Aug 2018 |
Sponsor / Collaborator |
Start Date02 Apr 2018 |
Sponsor / Collaborator |